Biofrontera Inc. — Director's Dealing 2025

Sep 18, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Biofrontera Inc. (BFRI)
CIK: 0001858685
Period of Report: 2025-09-16

Reporting Person: Biofrontera AG (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-09-16	Series D Convertible Preferred Stock	$0.0006	P	3019	Acquired		Common Stock (4831172)	Direct

Footnotes

F1: The convertible preferred stock is convertible at any time, at the holder's election, and has no expiration date.

F2: The reporting person acquired the convertible preferred stock in a privately negotiated transaction in exchange for assets related to the production and sale of certain products in the United States having an estimated market value of approximately $3,019,000.